The Origin of Allosteric Functional Modulation: Multiple Pre-existing Pathways
Antonio del Sol,Chung-Jung Tsai,Buyong Ma,Ruth Nussinov
DOI: https://doi.org/10.1016/j.str.2009.06.008
IF: 5.871
2009-01-01
Structure
Abstract:Although allostery draws increasing attention, not much is known about allosteric mechanisms. Here we argue that in all proteins, allosteric signals transmit through multiple, pre-existing pathways; which pathways dominate depend on protein topologies, specific binding events, covalent modifications, and cellular (environmental) conditions. Further, perturbation events at any site on the protein surface (or in the interior) will not create new pathways but only shift the pre-existing ensemble of pathways. Drugs binding at different sites or mutational events in disease shift the ensemble toward the same conformations; however, the relative populations of the different states will change. Consequently the observed functional, conformational, and dynamic effects will be different. This is the origin of allosteric functional modulation in dynamic proteins: allostery does not necessarily need to invoke conformational rearrangements to control protein activity and pre-existing pathways are always defaulted to during allostery regardless of the stimulant and perturbation site in the protein. Although allostery draws increasing attention, not much is known about allosteric mechanisms. Here we argue that in all proteins, allosteric signals transmit through multiple, pre-existing pathways; which pathways dominate depend on protein topologies, specific binding events, covalent modifications, and cellular (environmental) conditions. Further, perturbation events at any site on the protein surface (or in the interior) will not create new pathways but only shift the pre-existing ensemble of pathways. Drugs binding at different sites or mutational events in disease shift the ensemble toward the same conformations; however, the relative populations of the different states will change. Consequently the observed functional, conformational, and dynamic effects will be different. This is the origin of allosteric functional modulation in dynamic proteins: allostery does not necessarily need to invoke conformational rearrangements to control protein activity and pre-existing pathways are always defaulted to during allostery regardless of the stimulant and perturbation site in the protein. Proteins are the "workhorses" of the cell. Their response to changes in the cellular environment is modulated by an effector. The effector perturbs one site and thereby leads to an altered activity in a second, substrate site. Allostery is regulation at a distance by conveying the information from the first site to the second. Allostery is relayed through the cellular membrane, the cytoplasm and into the nucleus amplifying signaling (Ma and Nussinov, 2009Ma B. Nussinov R. Amplification of signaling via cellular allosteric relay and protein disorder.Proc. Natl. Acad. Sci. USA. 2009; 106: 6887-6888Crossref PubMed Scopus (32) Google Scholar) and the signals are sent dynamically (Smock and Gierasch, 2009Smock R.G. Gierasch L.M. Sending signals dynamically.Science. 2009; 324: 198-203Crossref PubMed Scopus (396) Google Scholar). Allostery can result from physical binding events (with proteins, DNA/RNA, small molecules, lipids); light, as the photoswitch LOV2-Jα illustrates, fluctuating between "dark" inactive and "light" active conformations (Yao et al., 2008Yao X. Rosen M.K. Gardner K.H. Estimation of the available free energy in a LOV2-J alpha photoswitch.Nat. Chem. Biol. 2008; 4: 491-497Crossref PubMed Scopus (103) Google Scholar); mutational events; covalent modifications (phosphorylation, glycosylation, tethering (Hardy et al., 2004Hardy J.A. Lam J. Nguyen J.T. O'Brien T. Wells J.A. Discovery of an allosteric site in the caspases.Proc. Natl. Acad. Sci. USA. 2004; 101: 12461-12466Crossref PubMed Scopus (198) Google Scholar); or changes in the environment (pH, temperature, ionic strength, etc.). Allostery was originally described in oligomeric systems (Changeux and Edelstein, 2005Changeux J.P. Edelstein S.J. Allosteric mechanisms of signal transduction.Science. 2005; 308: 1424-1428Crossref PubMed Scopus (539) Google Scholar). Two recent reviews (Cui and Karplus, 2008Cui Q. Karplus M. Allostery and cooperativity revisited.Protein Sci. 2008; 17: 1295-1307Crossref PubMed Scopus (472) Google Scholar, Goodey and Benkovic, 2008Goodey N.M. Benkovic S.J. Allosteric regulation and catalysis emerge via a common route.Nat. Chem. Biol. 2008; 4: 474-482Crossref PubMed Scopus (482) Google Scholar) provide a historical perspective: the first highlights cooperativity; the second emphasizes that catalysis and allostery emerge via common communication routes. Key questions include comprehensive description of allosteric mechanisms (Tsai et al., 2009Tsai C.J. Del Sol A. Nussinov R. Protein allostery, signal transmission and dynamics: a classification scheme of allosteric mechanisms.Mol. Biosyst. 2009; 5: 207-216Crossref PubMed Scopus (267) Google Scholar), prediction of allosteric sites whether on the protein surface or of residues whose mutation (Liu and Nussinov, 2008Liu J. Nussinov R. Allosteric effects in the marginally stable von Hippel-Lindau tumor suppressor protein and allostery-based rescue mutant design.Proc. Natl. Acad. Sci. USA. 2008; 105: 901-906Crossref PubMed Scopus (68) Google Scholar) could lead to allosteric effects, the pathways through which signals travel, and allosteric drug discovery. Currently, observation of specific pathways experimentally is a challenging problem. However, nuclear magnetic resonance (NMR) provides information on protein dynamics from which pathways can conceivably be inferred (Boehr et al., 2006Boehr D.D. McElheny D. Dyson H.J. Wright P.E. The dynamic energy landscape of dihydrofolate reductase catalysis.Science. 2006; 313: 1638-1642Crossref PubMed Scopus (715) Google Scholar, Kern and Zuiderweg, 2003Kern D. Zuiderweg E.R. The role of dynamics in allosteric regulation.Curr. Opin. Struct. Biol. 2003; 13: 748-757Crossref PubMed Scopus (527) Google Scholar, Swain and Gierasch, 2006Swain J.F. Gierasch L.M. The changing landscape of protein allostery.Curr. Opin. Struct. Biol. 2006; 16: 102-108Crossref PubMed Scopus (245) Google Scholar, Volkman et al., 2001Volkman B.F. Lipson D. Wemmer D.E. Kern D. Two-state allosteric behavior in a single-domain signaling protein.Science. 2001; 291: 2429-2433Crossref PubMed Scopus (517) Google Scholar). Recently, by using NMR relaxation dispersion techniques, the dynamic process through which the KIX domain of CREB binding protein communicates allosteric information was directly observed (Bruschweiler et al., 2009Bruschweiler S. Schanda P. Kloiber K. Brutscher B. Kontaxis G. Konrat R. Tollinger M. Direct observation of the dynamic process underlying allosteric signal transmission.J. Am. Chem. Soc. 2009; 131: 3063-3068Crossref PubMed Scopus (93) Google Scholar), revealing that information is transmitted through an evolutionarily conserved network of residues. Computationally, strategies for pathway identification have been proposed (del Sol et al., 2006del Sol A. Fujihashi H. Amoros D. Nussinov R. Residues crucial for maintaining short paths in network communication mediate signaling in proteins.Mol. Syst. Biol. 2006; 2 (2006.0019)Crossref PubMed Scopus (229) Google Scholar, del Sol et al., 2007del Sol A. Arauzo-Bravo M.J. Amoros D. Nussinov R. Modular architecture of protein structures and allosteric communications: potential implications for signaling proteins and regulatory linkages.Genome Biol. 2007; 8: R92Crossref PubMed Scopus (81) Google Scholar, Chennubhotla and Bahar, 2006Chennubhotla C. Bahar I. Markov propagation of allosteric effects in biomolecular systems: application to GroEL-GroES.Mol. Syst. Biol. 2006; 2: 36Crossref PubMed Scopus (123) Google Scholar). Below, we first briefly describe the principles of allostery, the "old" view, the so-called new view and an updated new view (Tsai et al., 2008Tsai C.J. Del Sol A. Nussinov R. Allostery: absence of a change in shape does not imply that allostery is not at play.J. Mol. Biol. 2008; 378: 1-11Crossref PubMed Scopus (348) Google Scholar). The "updated new" view leads us to re-address some of these questions. In particular, it highlights an allosteric property that has largely been overlooked: allostery invariably involves multiple pathways. Multiple pathways can relate to mutational effects in disease; to modulation in signaling pathways and to drug discovery. However, key to allostery, regardless of the site and nature of the perturbation events, propagation will take place via the same pathways. The different perturbation events will simply shift pre-existing populations. This is the origin of allosteric modulation in cellular pathways and in drug-binding effects. Over the years, static pictures of allosterically regulated proteins indicated a change in the shape of the substrate binding site between the On/Off states depending on whether the effector molecule was bound at the allosteric site. This has led to the paradigm that allostery involves conformational change. The two classical models, the Monod-Wyman-Changeux (or, MWC for short) (Monod et al., 1965Monod J. Wyman J. Changeux J.P. On the nature of allosteric transitions: a plausible model.J. Mol. Biol. 1965; 12: 88-118Crossref PubMed Scopus (5900) Google Scholar) and the Koshland-Nemethy-Filmer (KNF) (Koshland et al., 1966Koshland D.E. Nemethy G. Filmer D. Comparison of experimental binding data and theoretical models in proteins containing subunits.Biochemistry. 1966; 5: 365-385Crossref PubMed Scopus (2102) Google Scholar), described allostery as a binding event at one site altering protein activity via a conformational change at the second site. The MWC model (Monod et al., 1965Monod J. Wyman J. Changeux J.P. On the nature of allosteric transitions: a plausible model.J. Mol. Biol. 1965; 12: 88-118Crossref PubMed Scopus (5900) Google Scholar) emphasized that the conformational transition is a concerted action between two coexisting, distinct states (relaxed and tense, or R and T); the KNF model (Koshland et al., 1966Koshland D.E. Nemethy G. Filmer D. Comparison of experimental binding data and theoretical models in proteins containing subunits.Biochemistry. 1966; 5: 365-385Crossref PubMed Scopus (2102) Google Scholar) formulated it as a sequential, induced conformational change by the binding at the first site. The classical old view rested on two assumptions: that there are two distinct conformations and in the absence of a ligand their ratio is governed by the equilibrium constant; and that allostery involves a change of shape. In contrast to the old view, the more recent new view recognized that the native states are ensembles of pre-existing populations; thus, an allosteric effector leads to an equilibrium shift of pre-existing conformational and dynamic states (Gunasekaran et al., 2004Gunasekaran K. Ma B. Nussinov R. Is allostery an intrinsic property of all dynamic proteins?.Proteins. 2004; 57: 433-443Crossref PubMed Scopus (649) Google Scholar). Now, the updated new view posits that allostery does not necessarily even involve a change of shape (Tsai et al., 2008Tsai C.J. Del Sol A. Nussinov R. Allostery: absence of a change in shape does not imply that allostery is not at play.J. Mol. Biol. 2008; 378: 1-11Crossref PubMed Scopus (348) Google Scholar). Recent data (Daily and Gray, 2007Daily M.D. Gray J.J. Local motions in a benchmark of allosteric proteins.Proteins. 2007; 67: 385-399Crossref PubMed Scopus (86) Google Scholar, Popovych et al., 2006Popovych N. Sun S. Ebright R.H. Kalodimos C.G. Dynamically driven protein allostery.Nat. Struct. Mol. Biol. 2006; 13: 831-838Crossref PubMed Scopus (468) Google Scholar, Tsai et al., 2008Tsai C.J. Del Sol A. Nussinov R. Allostery: absence of a change in shape does not imply that allostery is not at play.J. Mol. Biol. 2008; 378: 1-11Crossref PubMed Scopus (348) Google Scholar) validate the theoretical proposition (Cooper and Dryden, 1984Cooper A. Dryden D.T.F. Allostery without conformational change: a plausible model.Eur. Biophys. J. 1984; 11: 103-109Crossref PubMed Scopus (480) Google Scholar), indicating that even if there is no visual change in the shape of the backbone at the substrate binding site upon binding of the allosteric effector, there could still be an allosteric change in the substrate binding site, and in protein activity. Popovych et al., 2006Popovych N. Sun S. Ebright R.H. Kalodimos C.G. Dynamically driven protein allostery.Nat. Struct. Mol. Biol. 2006; 13: 831-838Crossref PubMed Scopus (468) Google Scholar presented direct experimental evidence illustrating that allostery can be mediated solely by changes in protein dynamics without any conformational change. Daily and Gray assembled an allosteric protein benchmark of pairs of known inactive and active allosteric protein structures from the Protein Data Bank (PDB) (Berman et al., 2002Berman H.M. Battistuz T. Bhat T.N. Bluhm W.F. Bourne P.E. Burkhardt K. Feng Z. Gilliland G.L. Iype L. Jain S. et al.The Protein Data Bank.Acta Crystallogr. D Biol. Crystallogr. 2002; 58: 899-907Crossref PubMed Scopus (1591) Google Scholar). The data set includes structural pairs with no or subtle conformational change, governed largely by entropy (Daily and Gray, 2007Daily M.D. Gray J.J. Local motions in a benchmark of allosteric proteins.Proteins. 2007; 67: 385-399Crossref PubMed Scopus (86) Google Scholar). This absence of conformational change leads to a definition of allostery in pure thermodynamic terms: allostery can be controlled by enthalpy; by enthalpy and entropy; or solely by entropy (Tsai et al., 2008Tsai C.J. Del Sol A. Nussinov R. Allostery: absence of a change in shape does not imply that allostery is not at play.J. Mol. Biol. 2008; 378: 1-11Crossref PubMed Scopus (348) Google Scholar, Tsai et al., 2009Tsai C.J. Del Sol A. Nussinov R. Protein allostery, signal transmission and dynamics: a classification scheme of allosteric mechanisms.Mol. Biosyst. 2009; 5: 207-216Crossref PubMed Scopus (267) Google Scholar). This updated new view is important because it helps in understanding allosteric mechanisms and thus in prediction of allosteric sites, allostery-related residues, allosteric drugs, and allosteric modulation. The old view defined allostery in terms of two discrete states. It sought a single, well-defined propagation pathway between the allosteric- and substrate-binding sites that would lead to a conformational change. All allosteric residues were on this pathway and the signals were assumed to be transmitted by mechanically forming and breaking noncovalent interactions between on-pathway residues (Figure 1A). The old view was unable to offer an explanation for disease-causing (or, preventing [Trible et al., 2007Trible R.P. Emert-Sedlak L. Wales T.E. Ayyavoo V. Engen J.R. Smithgall T.E. Allosteric loss-of-function mutations in HIV-1 Nef from a long-term non-progressor.J. Mol. Biol. 2007; 374: 121-129Crossref PubMed Scopus (31) Google Scholar]) mutations that were not at the binding sites, retained the global protein conformation, and did not lie on that pathway. In contrast, in the new view (Figures 1B and 1C) it is not a specific propagation pathway but an ensemble of states (Gunasekaran et al., 2004Gunasekaran K. Ma B. Nussinov R. Is allostery an intrinsic property of all dynamic proteins?.Proteins. 2004; 57: 433-443Crossref PubMed Scopus (649) Google Scholar) that is the key for allostery; thus multiple pathways, major and minor, between the allosteric and the substrate binding sites. At the allosteric site noncovalent binding, covalent modification such as tethering, phosphorylation, or a point mutation create local stress. Local stress perturbs the structure, and the perturbation propagates via multiple pathways from the allosteric to the substrate binding sites. The PDZ2 domain interacts with a C-terminal peptide ligand obtained from the Ras-associated guanine nucleotide exchange factor 2 (RA-GEF2). It is known that binding site histidine 71 (hPTP1E PDZ2 numbering) determines the PDZ2 specificity, defining PDZ2 as class I PDZ domain (Kozlov et al., 2002Kozlov G. Banville D. Gehring K. Ekiel I. Solution structure of the PDZ2 domain from cytosolic human phosphatase hPTP1E complexed with a peptide reveals contribution of the beta2-beta3 loop to PDZ domain-ligand interactions.J. Mol. Biol. 2002; 320: 813-820Crossref PubMed Scopus (64) Google Scholar). For the PDZ domain family, Ranganathan and coworkers predicted and confirmed experimentally a set of energetically coupled positions for the binding site residue His71. In Figure 2A, this set of residues has been mapped onto the PDZ2/RA-GEF2 structure, forming a pathway that starts at the RA-GEF2 binding site and ends on the opposite side of the domain. Side-chain methyl dynamics measurements on the PDZ2 domain showed that allosteric transmissions due to RA-GEF2 peptide binding might be dominated by side-chain dynamics (Fuentes et al., 2004Fuentes E.J. Der C.J. Lee A.L. Ligand-dependent dynamics and intramolecular signaling in a PDZ domain.J. Mol. Biol. 2004; 335: 1105-1115Crossref PubMed Scopus (170) Google Scholar). Residues whose side-chain dynamics changed significantly upon peptide binding are also illustrated in Figure 2A. These residues form an alternative pathway starting at the peptide binding site and ending at two distal surface regions from the peptide binding site (see legend to Figure 2). These two pathways share common residues belonging to the protein core and distal surface 1. These findings based on the PDZ domain suggest the existence of multiple pathways from the perturbation to the substrate binding sites. The KIX domain of the CREB binding protein CBP provides another example of an allosteric protein with experimental data supporting the presence of multiple allosteric communication pathways. The KIX domain binds the mixed lineage leukemia transcription factor (MLL) inducing binding of the activation domain from c-Myb (Goto et al., 2002Goto N.K. Zor T. Martinez-Yamout M. Dyson H.J. Wright P.E. Cooperativity in transcription factor binding to the coactivator CREB-binding protein (CBP). The mixed lineage leukemia protein (MLL) activation domain binds to an allosteric site on the KIX domain.J. Biol. Chem. 2002; 277: 43168-43174Crossref PubMed Scopus (132) Google Scholar). Recently, using NMR relaxation measurements, a pathway through which the allosteric information is transmitted upon MLL binding was observed (Bruschweiler et al., 2009Bruschweiler S. Schanda P. Kloiber K. Brutscher B. Kontaxis G. Konrat R. Tollinger M. Direct observation of the dynamic process underlying allosteric signal transmission.J. Am. Chem. Soc. 2009; 131: 3063-3068Crossref PubMed Scopus (93) Google Scholar). This pathway, which is formed by hydrophobic amino acids experiencing significant structural rearrangements, proceeds from the MLL binding site toward the c-Myb binding site (Figure 2B). Interestingly, a previous NMR study identified a set of residues exhibiting significant backbone amide chemical shift changes upon MLL binding (Goto et al., 2002Goto N.K. Zor T. Martinez-Yamout M. Dyson H.J. Wright P.E. Cooperativity in transcription factor binding to the coactivator CREB-binding protein (CBP). The mixed lineage leukemia protein (MLL) activation domain binds to an allosteric site on the KIX domain.J. Biol. Chem. 2002; 277: 43168-43174Crossref PubMed Scopus (132) Google Scholar). These amino acids form a hydrophobic groove that contains MLL binding site residues and other solvent exposed residues belonging to a distinct protein surface and are possibly involved in binding of other ligands (Figure 2B). Thus, in this example, experimental results suggest the existence of two pathways that transmit the information to different protein surface patches. In allostery, perturbation at the effector site causes some activity change at the substrate site. The allosteric stimulus and activity change are illustrated as binding events. (A) The old view: An effector binds and causes an active site conformational change via a single propagation pathway, making an unfavorable substrate binding become favorable. (B and C) The two basic differences between the old and the updated new view. First, due to the nature of the thermodynamic equilibrium, the updated new view is based on population shift, and does not endorse the kinetic concept of propagating and releasing the strain energy created at the allosteric site via a single pathway; rather, it postulates that population shift from an off-state to an on-state (or vice-versa) must involve multiple pathways through network interactions. Panel B presents the multiple propagation pathways with an active site conformational change. Only pathways relating to such conformational change are shown. In panel (C), no conformational change is associated with the population shift; here, allostery is entropy dominated. Thermodynamically, population shift with an accompanied conformational change could be dominated by enthalpy or entropy; however, a free energy change without conformational change is entropy dominated. In the case of allostery with enthalpy-dominated conformational change, all propagation pathways effectively lead to the required conformational change. In positive cooperativity, the unfavorable active site conformation becomes substrate favorable. The opposite holds for negative cooperativity. For the case of entropy-dominated conformational change, consider an effector binding to disordered structure. This is positive cooperativity with entropy loss (disorder becomes order) prepaid by effector binding. Prepaid entropy via backbone and side-chain rigidification would be a case of entropy-dominated positive cooperativity without conformational change. In negative cooperativity without conformational change, effector binding enhances the dynamics; subsequent substrate-induced rigidification creates extra, nonadditive entropy loss. Above we focus on enthalpy- or entropy-dominated allostery; not a combination of both (Tsai et al., 2008Tsai C.J. Del Sol A. Nussinov R. Allostery: absence of a change in shape does not imply that allostery is not at play.J. Mol. Biol. 2008; 378: 1-11Crossref PubMed Scopus (348) Google Scholar). The realization of these two critical differences impacts the understanding and prediction of the allosteric effects. (A) Two possible pathways for allosteric communications upon RA-GEF2 peptide binding mapped onto the structure of PDZ2-RA-GEF2 (PDB code: 1D5G), with the RA-GEF2 peptide shown in yellow. In red are represented residues energetically coupled to His71 (Lockless and Ranganathan, 1999Lockless S.W. Ranganathan R. Evolutionarily conserved pathways of energetic connectivity in protein families.Science. 1999; 286: 295-299Crossref PubMed Scopus (973) Google Scholar). The black line depicts a pathway formed by these residues that starts at the peptide binding site residue His71 and splits into two subpathways that end at two residues located at the opposite side of the domain (A46 and V85). An alternative pathway composed of residues whose side-chain dynamics significantly change upon peptide binding (shown in blue) is represented with the white line (Fuentes et al., 2004Fuentes E.J. Der C.J. Lee A.L. Ligand-dependent dynamics and intramolecular signaling in a PDZ domain.J. Mol. Biol. 2004; 335: 1105-1115Crossref PubMed Scopus (170) Google Scholar). This pathway also starts at a peptide binding site residue (V26) and splits into two subpathways ending at two residues (A39 and T81) belonging to two distal surfaces from the peptide binding site (Fuentes et al., 2004Fuentes E.J. Der C.J. Lee A.L. Ligand-dependent dynamics and intramolecular signaling in a PDZ domain.J. Mol. Biol. 2004; 335: 1105-1115Crossref PubMed Scopus (170) Google Scholar), correspondingly. Distal surface 1 is composed of Thr81, Val85, Val61, Val64, Leu66, and Leu69, whereas distance surface 2 contains Ala39 and Val40. Residues shown in brown are common to both pathways. (B) Two alternative possible pathways for the transmission of perturbation upon ligand binding (MLL) on the structure of the complex KIX-MLL-c-Myb (PDB code: 2AGH). In red are residues that experience structural changes upon MLL binding (Bruschweiler et al., 2009Bruschweiler S. Schanda P. Kloiber K. Brutscher B. Kontaxis G. Konrat R. Tollinger M. Direct observation of the dynamic process underlying allosteric signal transmission.J. Am. Chem. Soc. 2009; 131: 3063-3068Crossref PubMed Scopus (93) Google Scholar). The black line depicts a pathway formed by these residues, which starts at the MLL binding site and ends at the c-Myb binding site. The yellow and pink helices correspond to MLL and c-Myb ligands, respectively. Residues colored in blue, which exhibit significant backbone chemical shift changes upon MLL binding (Goto et al., 2002Goto N.K. Zor T. Martinez-Yamout M. Dyson H.J. Wright P.E. Cooperativity in transcription factor binding to the coactivator CREB-binding protein (CBP). The mixed lineage leukemia protein (MLL) activation domain binds to an allosteric site on the KIX domain.J. Biol. Chem. 2002; 277: 43168-43174Crossref PubMed Scopus (132) Google Scholar), form a hydrophobic groove that links the MLL binding site with a distinct protein surface. This surface might be a novel binding site for other ligands. Residue F612 shown in brown is common to both networks of residues. An allosteric network has also been recently detected in caspase 1 (Datta et al., 2008Datta D. Scheer J.M. Romanowski M.J. Wells J.A. An allosteric circuit in caspase-1.J. Mol. Biol. 2008; 381: 1157-1167Crossref PubMed Scopus (68) Google Scholar). Of particular interest, 21 hydrogen bonds from nine side chains belonging to this network which connects the active and the allosteric sites were observed to alternate between the on-state and the off-state. Alanine-scanning mutagenesis of these side chains has shown that only two of these (Arg286 and Glu390), which form a salt bridge, have major effects on catalysis, reducing it by 100- to 200-fold. Two neighboring residues, Ser332 and Ser339, have minor effects, causing 4- to 7-fold reductions, suggesting that the salt-bridging residues are on the major allosteric pathway, whereas the neighboring residues might reside on a minor communication pathway (Figure 3). Further, even a homologous substitution of the salt-bridging residue R286K causes a large 150-fold reduction. The structures of these variants suggest that in addition to salt bridge formation, these residues play an important role in the coordination of solvent water molecules near the allosteric binding pocket. A critical salt bridge important for specificity in discriminating between binding partners has also been detected in p160 coactivator ACTR (Demarest et al., 2002Demarest S.J. Martinez-Yamout M. Chung J. Chen H. Xu W. Dyson H.J. Evans R.M. Wright P.E. Mutual synergistic folding in recruitment of CBP/p300 by p160 nuclear receptor coactivators.Nature. 2002; 415: 549-553Crossref PubMed Scopus (337) Google Scholar). Computationally, major and minor pathways have been detected in the tRNA synthetases (Sethi et al., 2009Sethi A. Eargle J. Black A.A. Luthey-Schulten Z. Dynamical networks in tRNA:protein complexes.Proc. Natl. Acad. Sci. USA. 2009; 106: 6620-6625Crossref PubMed Scopus (441) Google Scholar) and in the pVHL protein (Liu and Nussinov, 2008Liu J. Nussinov R. Allosteric effects in the marginally stable von Hippel-Lindau tumor suppressor protein and allostery-based rescue mutant design.Proc. Natl. Acad. Sci. USA. 2008; 105: 901-906Crossref PubMed Scopus (68) Google Scholar). The figure depicts a 15-residue chain with red bars indicating its backbone trace. Each residue is also given two exact interactions with its neighbors either via side chain-side chain or side chain-backbone interaction. The long brown bar indicates a strong interaction and short blue bar stands for a weak interaction. A micropathway is drawn starting from the perturbation site down to the second (substrate) site via the residue-residue interaction linkage (8→7→6→5→13). A mutation at residue 10 will not alter the allosteric effect because not a single residue-residue interaction has been changed. Although not formulated in allosteric terms, Ansari et al., 1985Ansari A. Berendzen J. Bowne S.F. Frauenfelder H. Iben I.E.T. Sauke T.B. Shyamsunder E. Young R.D. Protein states and protein quakes.Proc. Natl. Acad. Sci. USA. 1985; 82: 5000-5004Crossref PubMed Scopus (669) Google Scholar pointed out that similar to an earthquake, stress released from the focus could dissipate through propagation of deformation, and in the form of waves. From the theoretical standpoint, as in protein folding and in earthquake, in protein allostery a realistic scenario involves preferred pathways under given conditions. In principle, which pathway dominates can be determined from mutational effects: a mutation with a significant effect lies on a major pathway; a minor effect suggests a minor pathway. Mutations can break native state interactions and make new interactions (Figure 3). Although mutational effects can be assessed by the extent of the allosterically-related conformational change, this is not necessarily the case. The perturbation caused by the effector could be reflected solely in entropy changes with no observable conformational change (Tsai et al., 2008Tsai C.J. Del Sol A. Nussinov R. Allostery: absence of a change in shape does not imply that allostery is not at play.J. Mol. Biol. 2008; 378: 1-11Crossref PubMed Scopus (348) Google Scholar), as illustrated by Popovych et al., 2006Popovych N. Sun S. Ebright R.H. Kalodimos C.G. Dynamically driven protein allostery.Nat. Struct. Mol. Biol. 2006; 13: 831-838Crossref PubMed Scopus (468) Google Scholar and in structural comparisons of different allosteric states (Daily and Gray, 2007Daily M.D. Gray J.J. Local motions in a benchmark of allos